Zevra Therapeutics, Inc. (FRA:1GDA)
Germany flag Germany · Delayed Price · Currency is EUR
7.55
+0.25 (3.42%)
At close: Nov 28, 2025

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $26.06M USD in the quarter ending September 30, 2025, with 605.36% growth. This brings the company's revenue in the last twelve months to $84.39M, up 244.60% year-over-year. In the year 2024, Zevra Therapeutics had annual revenue of $23.61M, down -14.02%.

Revenue (ttm)
$84.39M
Revenue Growth
+244.60%
P/S Ratio
5.62
Revenue / Employee
$1.43M
Employees
59
Market Cap
403.88M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202423.61M-3.85M-14.02%
Dec 31, 202327.46M17.00M162.58%
Dec 31, 202210.46M-18.19M-63.50%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition